Alpha 2.0
Login Register
» Articles » PMID: 33864057

Fecal Microbiota Potentiate Checkpoint Inhibitors, Unleash Microbiome Startups

Overview
Journal Nat Biotechnol
Specialty Biotechnology
Date 2021 Apr 17
PMID 33864057
Citations 3
Authors
Mark Zipkin
Affiliations
Soon will be listed here.
Citing Articles

Immune-related adverse events in checkpoint blockade: Observations from human tissue and therapeutic considerations.

Williams K, Gault A, Anderson A, Stewart C, Lamb C, Speight R Front Immunol. 2023; 14:1122430.

PMID: 36776862 PMC: 9909476. DOI: 10.3389/fimmu.2023.1122430.

Microbiota and Colorectal Cancer: From Gut to Bedside.

Silva M, Brunner V, Tschurtschenthaler M Front Pharmacol. 2021; 12:760280.

PMID: 34658896 PMC: 8514721. DOI: 10.3389/fphar.2021.760280.

Novel insights on gut microbiota manipulation and immune checkpoint inhibition in cancer (Review).

Vivarelli S, Falzone L, Leonardi G, Salmeri M, Libra M Int J Oncol. 2021; 59(3).

PMID: 34396439 PMC: 8360620. DOI: 10.3892/ijo.2021.5255.